CN112755118A - 一种治疗羊传染性脓疱的复方制剂及其制备方法 - Google Patents

一种治疗羊传染性脓疱的复方制剂及其制备方法 Download PDF

Info

Publication number
CN112755118A
CN112755118A CN202110061360.2A CN202110061360A CN112755118A CN 112755118 A CN112755118 A CN 112755118A CN 202110061360 A CN202110061360 A CN 202110061360A CN 112755118 A CN112755118 A CN 112755118A
Authority
CN
China
Prior art keywords
parts
preparation
sheep
mixture
aspirin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110061360.2A
Other languages
English (en)
Inventor
陶立
李常挺
彭昊
吴翠兰
黄海莲
马春霞
李军
兰美益
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi Veterinary Research Institute
Original Assignee
Guangxi Veterinary Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Veterinary Research Institute filed Critical Guangxi Veterinary Research Institute
Priority to CN202110061360.2A priority Critical patent/CN112755118A/zh
Publication of CN112755118A publication Critical patent/CN112755118A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • A61K36/195Strobilanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315Isatis, e.g. Dyer's woad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供一种治疗羊传染性脓疱的复方制剂及其制备方法,所述的药剂包括以下组分:大黄、黄柏、黄连、黄芩、青黛、浙贝母、冰片、薄荷脑、甘草、阿司匹林、冰醋酸、无水乙醇和甘油。本发明根据羊传染性脓疱发病的症状和特点,充分利用冰醋酸的杀菌灭毒、阿司匹林外用抗真菌作用和中兽药的清热泻火、消肿止痛、散结消炎和解毒镇痛等特点,经无水乙醇和甘油调配而形成的一个新的搽剂药剂,对皮肤和黏膜刺激性少,涂抹时不会使羔羊产生应激反应,可以有效的对羊传染性脓疱进行治疗,具有很强的散结、镇痛和退热的作用,见效快,疗效确实。

Description

一种治疗羊传染性脓疱的复方制剂及其制备方法
技术领域
本发明属于兽药技术领域,特别涉及一种治疗羊传染性脓疱的复方制剂及其制备方法。
背景技术
羊传染性脓疱(羊口疮)是由传染性脓疱病毒引起的山羊和绵羊的高度接触性的传染病,以口腔周围皮肤和黏膜出现红斑、丘疹、水泡、脓疱至溃烂、真皮结缔组织增生形成疣状厚痂为特征,在口腔的周围造成红肿和炎症,影响羔羊的采食,严重危害羔羊生长发育,还可寄发其他病原菌感染,造成更大危害。该病在3~6月龄的羔羊中可群发流行,发病率40%~60%,病死率5%~10%左右,临床常用碘甘油或紫药水、冰硼散等治疗,碘甘油刺激性大,羔羊应激反应严重,紫药水已禁用,而且效果也不理想,硼砂有明确的致癌作用。因此,临床上研究和探求一种刺激性少、效果理想的药物非常有必要。
发明内容
针对现有用于治疗羊传染性脓疱的药剂存在的效果不佳的缺陷,本发明提供一种治疗羊传染性脓疱的复方制剂及其制备方法,结合中西药制备成一种新的搽剂剂型。
本发明是通过以下技术方案实现的:
一种治疗羊传染性脓疱的复方制剂,包括以下重量份数比组分:大黄1~4份、黄柏2~5份、黄连1~3份、黄芩2~6份、青黛3~6份、浙贝母2~5份、冰片0.3~1.5份、薄荷脑0.1~1份、甘草1~5份和阿司匹林1~2份。
所述的治疗羊传染性脓疱的复方制剂的制备方法,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将1~2份阿司匹林用25~28份无水乙醇充分溶解,然后加入1.6~2.4份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入1~5份冰醋酸和66~72份甘油,搅拌至充分混匀,使各成分最终浓度为无水乙醇25%~28%(v/v),甘油66%~72%(v/v),冰醋酸1%~5%(v/v),阿司匹林1%~2%(w/v),混合物A1.6%~2.4%(w/v),即得到复方制剂。
优选的,所述的阿司匹林和冰醋酸的用量比为(1~2):(1~5)(W/V)。
优选的,所述的各成分最终浓度为无水乙醇27%(v/v),甘油70%(v/v),冰醋酸3%(v/v),阿司匹林1%(w/v),混合物A 2%(w/v)。
本发明的有益效果:
1、本发明根据羊传染性脓疱发病的症状和特点,充分利用冰醋酸的杀菌灭毒、阿司匹林外用抗真菌作用和中药的清热泻火、消肿止痛、散结消炎和解毒镇痛等特点,经无水乙醇和甘油调配而形成的一个新的搽剂剂,可以使制备的复方制剂药性温和,对皮肤和黏膜刺激性少,涂抹时不会使羔羊产生应激反应。
2、本发明的制剂配以温和且针对传染性脓疱病毒的中药,与冰醋酸、阿司匹林杀菌杀毒和抗真菌作用结合,可以有效的对羊传染性脓疱进行治疗,具有很强的散结、镇痛和退热、防止继发感染的作用,见效快,疗效确实。
具体实施方式
下面结合实施例对本发明作进一步说明。
实施例1
一种治疗羊传染性脓疱的复方制剂,包括以下重量份数比组分:大黄1份、黄柏2份、黄连1份、黄芩2份、青黛3份、浙贝母2份、冰片1份、薄荷脑0.5份和甘草3份。
所述的治疗羊传染性脓疱的复方制剂的制备方法,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将1份阿司匹林用25份无水乙醇充分溶解,然后加入1.6份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入5份冰醋酸和73份甘油,搅拌至充分混匀成为搽剂,使各成分最终浓度为无水乙醇25%(v/v),甘油73%(v/v),冰醋酸2%(v/v),阿司匹林1%(w/v),混合物A1.6%(w/v),即得到复方制剂。
实施例2
一种治疗羊传染性脓疱的复方制剂,包括以下重量份数比组分:大黄4份、黄柏5份、黄连3份、黄芩6份、青黛6份、浙贝母5份、冰片1.5份、薄荷脑1份和甘草5份。
所述的治疗羊传染性脓疱的复方制剂的制备方法,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将2份阿司匹林用28份无水乙醇充分溶解,然后加入2.4份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入4份冰醋酸和68份甘油,搅拌至充分混匀成为搽剂,使各成分最终浓度为无水乙醇28%(v/v),甘油68%(v/v),冰醋酸4%(v/v),阿司匹林1.5%(w/v),混合物A 2.4%(w/v),即得到复方制剂。
实施例3
一种治疗羊传染性脓疱的复方制剂,包括以下重量份数比组分:大黄2份、黄柏2份、黄连2份、黄芩2份、青黛3份、浙贝母3份、冰片0.3份、薄荷脑0.1份和甘草1份。
所述的治疗羊传染性脓疱的复方制剂的制备方法,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将3份阿司匹林用27份无水乙醇充分溶解,然后加入2份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入3份冰醋酸和70份甘油,搅拌至充分混匀成为搽剂,使各成分最终浓度为无水乙醇27%(v/v),甘油70%(v/v),冰醋酸3%(v/v),阿司匹林1%(w/v),混合物A 2%(w/v),即得到复方制剂。
实施例4
一种治疗羊传染性脓疱的复方制剂,包括以下重量份数比组分:大黄2份、黄柏2份、黄连2份、黄芩2份、青黛3份、浙贝母3份、冰片0.3份、薄荷脑0.1份和甘草1份。
所述的治疗羊传染性脓疱的复方制剂的制备方法,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将2份阿司匹林用30份无水乙醇充分溶解,然后加入2份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入1份冰醋酸和68份甘油,搅拌至充分混匀成为搽剂,使各成分最终浓度为无水乙醇30%(v/v),甘油68%(v/v),冰醋酸1%(v/v),阿司匹林2%(w/v),混合物A 2%(w/v),即得到复方制剂。
应用例
样本:一养殖户10只羊传染性脓疱(羊口疮)自然发病的3~6月龄的山羊。
药品:A:实施例1、2、3、4制备的制剂;B:市售1%碘甘油。
使用方法:
(1)在相同的饲养管理条件下,将10只羊传染性脓疱(羊口疮)自然病例的山羊按症状严重程度均匀分成2组,每组5只,1组涂搽A药,1组涂搽B药。
(2)搽药前每只病羊均人工去除羊口疮的痂皮,并用淡盐水清洗血迹和创口,用干净的卫生纸吸干创口及其周边的水分。用药棉或棉签醮取药液分别涂于创口面上,每天早、晚各用药1次,每天观察用药效果并记录,直至用药全好为止。
疗效对比见表1
表1
Figure BDA0002902773200000031
Figure BDA0002902773200000041
以上实施例仅为本发明的示例性实施例,不用于限制本发明,本发明的保护范围由权利要求书限定。本领域人员可以在本发明的实质和保护范围内,对本发明做出各种修改或等同替换,这种修改或等同替换也应视为落在本发明的保护范围内。

Claims (4)

1.一种治疗羊传染性脓疱的复方制剂,其特征在于,包括以下重量份数比组分:大黄1~4份、黄柏2~5份、黄连1~3份、黄芩2~6份、青黛3~6份、浙贝母2~5份、冰片0.3~1.5份、薄荷脑0.1~1份、甘草1~5份和阿司匹林1~2份。
2.如权利要求1所述的治疗羊传染性脓疱的复方制剂的制备方法,其特征在于,包括以下步骤:
(1)将上述重量份数组分研磨过80目筛成粉,然后混合均匀,得到混合物A;
(2)将1~2份阿司匹林用25~28份无水乙醇充分溶解,然后加入1.6~2.4份混合物A,搅拌至冰片和薄荷脑完全溶解,得到混合物B;
(3)在混合物B中加入1~5份冰醋酸和66~72份甘油,搅拌至充分混匀,使各成分最终浓度为无水乙醇25%~28%(v/v),甘油66%~72%(v/v),冰醋酸1%~5%(v/v),阿司匹林1%~2%(w/v),混合物A1.6%~2.4%(w/v),即得到复方制剂。
3.根据权利要求2所述的治疗羊传染性脓疱的复方制剂的制备方法,其特征在于:所述的阿司匹林和冰醋酸的用量比为(1~2):(1~5)(W/V)。
4.根据权利要求2所述的治疗羊传染性脓疱的复方制剂的制备方法,其特征在于:所述的各成分最终浓度为无水乙醇27%(v/v),甘油70%(v/v),冰醋酸3%(v/v),阿司匹林1%(w/v),混合物A 2%(w/v)。
CN202110061360.2A 2021-01-18 2021-01-18 一种治疗羊传染性脓疱的复方制剂及其制备方法 Withdrawn CN112755118A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110061360.2A CN112755118A (zh) 2021-01-18 2021-01-18 一种治疗羊传染性脓疱的复方制剂及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110061360.2A CN112755118A (zh) 2021-01-18 2021-01-18 一种治疗羊传染性脓疱的复方制剂及其制备方法

Publications (1)

Publication Number Publication Date
CN112755118A true CN112755118A (zh) 2021-05-07

Family

ID=75702339

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110061360.2A Withdrawn CN112755118A (zh) 2021-01-18 2021-01-18 一种治疗羊传染性脓疱的复方制剂及其制备方法

Country Status (1)

Country Link
CN (1) CN112755118A (zh)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104000916A (zh) * 2014-05-08 2014-08-27 思南县双红种养专业合作社 一种治疗羊传染性脓疱的组合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104000916A (zh) * 2014-05-08 2014-08-27 思南县双红种养专业合作社 一种治疗羊传染性脓疱的组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
黄尤珍等: "复方西瓜霜治疗羊传染性脓疱性口膜炎", 《中兽医医药杂志》 *

Similar Documents

Publication Publication Date Title
CN105833279B (zh) 皮肤多种损伤创面治疗的外用药物组合物及其制备方法
CN103341184B (zh) 一种超声耦合剂及制备方法
CN113081928B (zh) 一种植物抑菌凝胶及其制备方法和应用
EA018425B1 (ru) Фармацевтический, дезинфицирующий или консервирующий экстракт пажитника сенного (trigonella foenum-graecum), способ его получения и применение экстракта
CN103751812A (zh) 一种超声耦合剂及制备方法
CN112755118A (zh) 一种治疗羊传染性脓疱的复方制剂及其制备方法
CN111803624A (zh) 一种含有转移因子的皮肤抗菌凝胶制剂和制备方法
US11806376B2 (en) Pharmaceutical composition for treating oral ulcer and preparation method and application thereof
CN107854696B (zh) 一种结膜型医用超声耦合剂及其制备方法与使用方法
CN108721442B (zh) 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法
CN104645117A (zh) 一种检验科用中药消毒液
CN107913234A (zh) 一种鹿茸草牙膏及其制备方法
CN109464521B (zh) 一种用于防治鸡支气管栓塞的中药组合物
CN103920010B (zh) 具有止血止痛及抗炎作用的药物组合物及其制备方法和用途
CN101301389B (zh) 一种治疗奶牛乳头乳池赘生物病的中药组合物及其制备方法和用途
CN113813308A (zh) 一种治疗烧烫伤的药物及其制备方法
CN101972451B (zh) 一种治疗奶牛子宫炎的中西药复方灌注剂及其制备方法
CN108403825B (zh) 一种治疗羊口疮的中药物及其制备方法
RU2810482C1 (ru) Лекарственная композиция ТКМ и её применение в профилактике и лечении вирусной пневмонии
CN103860658B (zh) 红茂草提取物在外伤及传染性化脓性皮肤炎药物中的应用
CN114129493B (zh) 一种天麻免洗抑菌凝胶及其制备方法和应用
CN115400172B (zh) 一种治疗蚊虫叮咬的中药组合物及其制备方法
CN1157736A (zh) 肺炎治疗仪专用给药贴片配方及生产工艺
CN107519355B (zh) 一种治疗咽喉疾病的青梅及其制备方法
CN105560837A (zh) 治疗皮肤损伤的药物及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210507

WW01 Invention patent application withdrawn after publication